about
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causi...
Read More
3.52
0.25
(7.65%)
4.9M
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
Rezolute Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..